biote Corp. Fundamental Analysis
biote Corp. (BTMD) shows weak financial fundamentals with a PE ratio of 4.49, profit margin of 8.29%, and ROE of -22.91%. The company generates $0.3B in annual revenue with weak year-over-year growth of -2.52%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 28.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze BTMD's fundamental strength across five key dimensions:
Efficiency Score
ExcellentBTMD demonstrates superior asset utilization.
Valuation Score
ExcellentBTMD trades at attractive valuation levels.
Growth Score
WeakBTMD faces weak or negative growth trends.
Financial Health Score
ExcellentBTMD maintains a strong and stable balance sheet.
Profitability Score
WeakBTMD struggles to sustain strong margins.
Key Financial Metrics
Is BTMD Expensive or Cheap?
P/E Ratio
BTMD trades at 4.49 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, BTMD's PEG of -0.15 indicates potential undervaluation.
Price to Book
The market values biote Corp. at -1.25 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -0.06 times EBITDA. This is generally considered low.
How Well Does BTMD Make Money?
Net Profit Margin
For every $100 in sales, biote Corp. keeps $8.29 as profit after all expenses.
Operating Margin
Core operations generate 16.99 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-22.91 in profit for every $100 of shareholder equity.
ROA
biote Corp. generates $17.53 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
biote Corp. produces operating cash flow of $46.96M, showing steady but balanced cash generation.
Free Cash Flow
biote Corp. generates strong free cash flow of $41.29M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.94 in free cash annually.
FCF Yield
BTMD converts 28.59% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
4.49
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.15
vs 25 benchmark
P/B Ratio
Price to book value ratio
-1.25
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.54
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-1.93
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.29
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.23
vs 25 benchmark
ROA
Return on assets percentage
0.18
vs 25 benchmark
ROCE
Return on capital employed
0.53
vs 25 benchmark
How BTMD Stacks Against Its Sector Peers
| Metric | BTMD Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 4.49 | 29.17 | Better (Cheaper) |
| ROE | -22.91% | 726.00% | Weak |
| Net Margin | 8.29% | -51406.00% (disorted) | Weak |
| Debt/Equity | -1.93 | 0.49 | Strong (Low Leverage) |
| Current Ratio | 1.29 | 4.40 | Neutral |
| ROA | 17.53% | -21737.00% (disorted) | Strong |
BTMD outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROA, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews biote Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-60.07%
Industry Style: Defensive, Growth, Innovation
DecliningEPS CAGR
-77.55%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
-67.75%
Industry Style: Defensive, Growth, Innovation
Declining